Tyrosine Kinase Inhibitors: all 10,744 studies that test it
Page 98 of 108. Open to participants first (1,949), then studies with results posted, then the rest; newest registration first within each.
- Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerCompletedNCT00792025Phase 2
- Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver CarcinomaTerminatedNCT00791544Phase 1/2
- Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical ProstatectomyCompletedNCT00790595Phase 1
- Phase II Study of TKI258 in Advanced Urothelial CarcinomaCompletedNCT00790426Phase 2
- Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic CarcinomaCompletedNCT00789763Phase 1
- Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic CancerCompletedNCT00789633Phase 3
- Single and Multiple Dose Escalation Study of VX-509 in Healthy SubjectsCompletedNCT00789126Phase 1
- S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid TumorsWithdrawnNCT00788580Phase 1
- Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast CancerCompletedNCT00788333Phase 1/2
- Subretinal Macugen® for Neovascular Age-Related Macular DegenerationStatus unknownNCT00788177Phase 3
- Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or LymphomasCompletedNCT00788099Phase 1
- A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell CarcinomaCompletedNCT00788060Phase 1
- An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant MesotheliomaCompletedNCT00787410Phase 2
- Efficacy of Imatinib Mesylate in Hypereosinophilic SyndromesCompletedNCT00787384Phase 2
- A Study Of PF-04554878 In Patients With Advanced Non-Hematologic MalignanciesCompletedNCT00787033Phase 1
- Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic PhaseCompletedNCT00786812Phase 4
- Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer PatientsStatus unknownNCT00786110Phase 2
- RDEA119 and Sorafenib Combination Dose Escalation StudyCompletedNCT00785226Phase 1/2
- Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and ErlotinibStatus unknownNCT00784667Phase 2
- Phase I/II Study of TSU-68 for Advanced Hepatocellular CarcinomaCompletedNCT00784290Phase 1/2
- Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 YearsCompletedNCT00783653Phase 1/2
- Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00783471Phase 2
- A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid TumorsCompletedNCT00783328Phase 1
- Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver DiseaseCompletedNCT00781430Phase 1
- Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal CancerCompletedNCT00780169Phase 1
- Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled TrialCompletedNCT00779493Phase 4
- Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)TerminatedNCT00779480Phase 1
- Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC FamilyCompletedNCT00779389Phase 1
- Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid TumorsCompletedNCT00777699Phase 1
- Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy SubjectsCompletedNCT00777530Phase 1
- A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00777309Phase 2
- Adjuvant Pazopanib in Stage I NSCLCCompletedNCT00775307Phase 2/3
- Safety Study of TAK-593 Given Orally in Subjects With Nonhematologic Advanced CancerCompletedNCT00773929Phase 1
- Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to ChemotherapyStatus unknownNCT00772694Phase 2
- Relative Bioavailability of Phase II and Phase III Formulations of AZD0530CompletedNCT00771979Phase 1
- Erlotinib and Temsirolimus for Solid TumorsCompletedNCT00770263Phase 1
- Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesWithdrawnNCT00769990Phase 1/2
- Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00769327Phase 2
- Sorafenib and Transarterial Chemoembolization for Hepatocellular CarcinomaCompletedNCT00768937Phase 1/2
- CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma MultiformeStatus unknownNCT00768911Phase 1
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and CirrhosisTerminatedNCT00767468Phase 1
- Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast CancerStatus unknownNCT00764972Phase 1/2
- Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal TumorCompletedNCT00764595Phase 2
- Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL PositiveCompletedNCT00763763Phase 2
- Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid LeukemiaCompletedNCT00762632Phase 1/2
- A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host DiseaseCompletedNCT00760981Phase 1
- PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid TumorsCompletedNCT00759928Phase 1
- Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy SubjectsCompletedNCT00759837Phase 1
- Metastatic Advanced Pancreas SorafenibStatus unknownNCT00758381Phase 2
- Study Evaluating The Tolerability Of Multiple Doses Of HKI-272CompletedNCT00757809Phase 1
- Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.CompletedNCT00757692Phase 2
- Study Evaluating The Mass Balance And Metabolic Disposition Of SKI-606CompletedNCT00757341Phase 1
- Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast CancerTerminatedNCT00754702Phase 2
- Study of ABT-869 in Combination With Tarceva in Subjects With Solid TumorsWithdrawnNCT00754104Phase 1
- Sunitinib and Radiation in Patients With Resectable Soft-tissue SarcomaStatus unknownNCT00753727Phase 1/2
- Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus ErythematosusWithdrawnNCT00752999Phase 2
- Curcumin in Rheumatoid ArthritisCompletedNCT00752154Early Phase 1
- Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular CarcinomaStatus unknownNCT00752063Phase 2
- Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid TumoursActive, not recruitingNCT00750841Phase 1
- Nilotinib Pre and Post Allogeneic Stem Cell TransplantationCompletedNCT00750659Phase 2
- Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid TumoursCompletedNCT00750425Phase 1
- Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung CancerTerminatedNCT00749567Phase 2
- DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)CompletedNCT00748891Phase 1
- An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate CancerCompletedNCT00748358Phase 2
- Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT00747799Phase 2
- Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By SurgeryTerminatedNCT00747305Phase 1
- Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00745732Phase 1
- A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic MyelofibrosisCompletedNCT00745550Phase 1/2
- Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)CompletedNCT00744081Phase 2
- A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLCCompletedNCT00743938Phase 2
- A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid TumorsCompletedNCT00743067Phase 1
- A Bioavailability Study of GSK1363089 in Subjects With Solid TumorsCompletedNCT00742261Phase 1
- A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid TumorsCompletedNCT00742131Phase 1
- A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid MalignanciesCompletedNCT00741871Phase 1
- A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)CompletedNCT00739453Phase 1
- Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract CancersCompletedNCT00738751Phase 1
- Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesWithdrawnNCT00738335Phase 1
- Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00734890Phase 1
- Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or GliosarcomaTerminatedNCT00734526Phase 1
- Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869CompletedNCT00733187Phase 1
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918TerminatedNCT00733031Phase 1
- Sequential Study to Treat Renal Cell CarcinomaCompletedNCT00732914Phase 3
- Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy VolunteersCompletedNCT00732888Phase 1
- Effect of Calcium on Gleevec Pharmacokinetics (PK) in Healthy VolunteersCompletedNCT00732784Phase 1
- Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal JunctionTerminatedNCT00732745Phase 1
- Open-label Study of Topotecan and Pazopanib in Advanced Solid TumorsCompletedNCT00732420Phase 1
- Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid TumorsCompletedNCT00731861Phase 1
- Phase I of BIBW 2992/BIBF 1120 Combination Therapy in Solid TumorsCompletedNCT00730821Phase 1
- Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008)CompletedNCT00729742Phase 1
- A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid TumorsCompletedNCT00728793Phase 1
- A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 WeeksCompletedNCT00728390Phase 1
- Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic AdenocarcinomaWithdrawnNCT00728000Phase 2
- Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform NeurofibromasCompletedNCT00727233Phase 1
- A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple MyelomaCompletedNCT00725634Phase 1
- Effect of Rifampin on Bosutinib When Both Are Given to Healthy PeopleCompletedNCT00725426Phase 1
- Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerStatus unknownNCT00722969Phase 2
- A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid TumorsCompletedNCT00722293Phase 1
- Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy SubjectsCompletedNCT00721474Phase 1
- A Phase I Trial of Bortezomib and SunitinibCompletedNCT00720148Phase 1
- A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid MalignanciesCompletedNCT00719836Phase 1/2